BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.3//EN
X-ORIGINAL-URL:https://biiworld.com/
X-WR-CALNAME:BII World
X-WR-CALDESC:Engage | Empower | Enlighten
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Asia/Kolkata:20230717T130000
DTEND;TZID=Asia/Kolkata:20230721T170000
DTSTAMP:20230606T191300
UID:MEC-aba22f748b1a6dff75bda4fd1ee9fe07@biiworld.com
CREATED:20230607
LAST-MODIFIED:20230607
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:Biorelevant Dissolution Testing
DESCRIPTION:\nReal Time Online Delivery – Live Training Sessions\nVirtual Attendance for 5 Days Training \nGuided Learning Hours – 20\nCase Studies, Practical Exercises, Q & A, \nPre-Course Access: Intro Session Coupon, Pre-Event Questionnaire, Presentation Slide Deck\n\nCourse Overview\nDissolution testing can play an important role in several areas for drug products as a quality control tool to monitor batch-to-batch consistency of drug release from a dosage form and as an in vitro surrogate for in vivo performance that can guide formulation development and ascertain the need for bioequivalence (BE) testing. The possibility of substituting dissolution tests for clinical studies has been revealed by the development of the Biopharmaceutics Classification System (BCS), and dissolution tests that can predict the in vivo performance of drug products could serve this purpose.\nThis 5 Day Online Course will highlight the uses of dissolution/release testing as a tool during the drug development and routine quality control, and will focus on some of the main considerations for dissolution test development, especially in an era where the majority of drugs in development are poorly soluble.\nThese Daily 4 Hrs sessions will discuss some of the most useful practices and procedures that might contribute to better planning, designing, and development of different types of dosage form based on dissolution testing, leading to a successful regulatory submission and approval within the planned costs and time.\nTrainer’s Profile\nOur Expert Trainer is a Fellow of Royal Society of Chemistry (RSC) with over 30+ years of experience as an analytical chemist. An expert in sampling and sample preparation, chromatography, spectroscopy & pharmaceutical dissolution testing!\nA Phd degree in analytical chemistry, our expert worked at a senior level in a number of industrial laboratories with responsibility for the development of analytical methods.\nOur Expert has provided numerous Public & In-House Lectures, Workshops, and Seminars in recent past.\nKey Takeaways\n\nRegulatory acceptability of dissolution conditions\nCorrelation with in vivo performance\nDissolution theory\nRequirements for different dosage forms/release profiles\nEquipment Qualification\nSuccessful method development strategies\nInvestigating anomalous results\nRelease testing for novel dosage forms\nBiorelevant media\n\nWho Should Attend\n\nAnalytical Development Scientists\nQuality Control Scientists\nFormulation Development Scientists\nRegulatory Affairs (RA) Delegates\nQA / QC Managers\nChemistry Manufacturing and Controls (CMC) representatives\nProject Managers\nQualified Persons\nAny executives that would like to expand their knowledge in biorelevant dissolution testing\n\n\nFor participation details contact\nMithun Siddartha\nmithun.siddartha@biiworld.com ( mailto:mithun.siddartha@biiworld.com )\n+1 780 851 7197 (Canada)\nFill the details below to request your Brochure\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
URL:https://biiworld.com/trainings/biorelevant-dissolution-testing-17-21-july-2023/
ATTACH;FMTTYPE=image/jpeg:https://biiworld.com/wp-content/uploads/2020/06/Biorelevant-Dissolution-Testing-Methodologies-Application-in-Drug-Development-1.jpg
END:VEVENT
END:VCALENDAR